315 related articles for article (PubMed ID: 2535828)
1. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
3. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
Ferrier C; Beretta-Piccoli C; Weidmann P; Gnädinger MP; Shaw S; Suchecka-Rachon K; Saxenhofer H
Am J Nephrol; 1989; 9(4):291-9. PubMed ID: 2530903
[TBL] [Abstract][Full Text] [Related]
4. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
5. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.
Ginès P; Titó L; Arroyo V; Llach J; Salmerón JM; Ginès A; Jiménez W; Badalamenti S; Rivera F; Rodés J
Gastroenterology; 1992 Jan; 102(1):280-6. PubMed ID: 1290472
[TBL] [Abstract][Full Text] [Related]
6. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
[TBL] [Abstract][Full Text] [Related]
7. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Gentile S; Bologna E; Terracina D; Angelico M
Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
[TBL] [Abstract][Full Text] [Related]
8. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
[TBL] [Abstract][Full Text] [Related]
9. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.
Skorecki KL; Leung WM; Campbell P; Warner LC; Wong PY; Bull S; Logan AG; Blendis LM
Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047
[TBL] [Abstract][Full Text] [Related]
10. Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol.
Morali GA; Tobe SW; Skorecki KL; Blendis LM
Hepatology; 1992 Jul; 16(1):42-8. PubMed ID: 1535608
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
[TBL] [Abstract][Full Text] [Related]
12. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
[TBL] [Abstract][Full Text] [Related]
13. Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis.
Beutler JJ; Koomans HA; Rabelink TJ; Gaillard CA; Van Hattum J; Boer P; Dorhout Mees EJ
Hepatology; 1989 Aug; 10(2):148-53. PubMed ID: 2526072
[TBL] [Abstract][Full Text] [Related]
14. Assessment of atrial natriuretic peptide resistance in cirrhosis with head-out water immersion and atrial natriuretic peptide infusion.
Legault L; Warner LC; Leung WM; Logan AG; Blendis LM; Skorecki KL
Can J Physiol Pharmacol; 1993 Feb; 71(2):157-64. PubMed ID: 8319139
[TBL] [Abstract][Full Text] [Related]
15. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
Moe GW; Canepa-Anson R; Armstrong PW
J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
[TBL] [Abstract][Full Text] [Related]
18. Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion.
Badalamenti S; Borroni G; Lorenzano E; Incerti P; Salerno F
Hepatology; 1992 May; 15(5):824-9. PubMed ID: 1533201
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
[TBL] [Abstract][Full Text] [Related]
20. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Ando M
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
